New
findings from the Institute of Food Research are providing insights into the
interaction between bacteria and mucins, and how the specificity of these
interactions affects health. The IFR researchers looked at Ruminococcus gnavus. This is a common species of gut bacteria found
in over 90% of people, including infants just a few days old. It has also been
implicated in gut-related health conditions. A number of studies have shown
that patients suffering from Inflammatory Bowel Diseases have a
disproportionate representation of R.
gnavus.
This
study looked at two different R. gnavus
strains. Although both R. gnavus
strains can use mucins, only one had the ability to survive when mucins were
the sole source of food.
Comparing
the genomes of the R. gnavus strains
identified gene clusters used to breakdown mucins. Differences in these genes
explain the different abilities of the strains to use mucins. The mucin sugar
structures change in different parts of the gut and over time, suggesting the
strains may be adapted for different environments or to colonise us at
different times. For example, the R.
gnavus strain adapted to survive solely on mucins may give it the ability
to colonise the guts of newborn babies, when mucins represent the only sources
of sugars for bacteria. In adults, the strains of bacteria that degrade mucins
are the ones most likely to contact the cells underneath the mucus and so these
strains are the ones most likely to influence health.
For
further details, see the following paper:
Emmanuelle H. Crost, Louise E. Tailford, Gwenaelle Le Gall, Michel
Fons, Bernard Henrissat, Nathalie Juge. Utilisation of Mucin Glycans by the Human Gut
Symbiont Ruminococcus gnavus Is Strain-Dependent. PLoS ONE, 2013; 8 (10):
e76341 DOI: 10.1371/journal.pone.0076341
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources